Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Makoto Hoshino, Kenta Akitsu & Junichi Ohtawa. (2019) Comparison between montelukast and tiotropium as add-on therapy to inhaled corticosteroids plus a long-acting β2-agonist in for patients with asthma. Journal of Asthma 56:9, pages 995-1003.
Read now
Read now
Naim Kittana, Suhaib Hattab, Azza Ziyadeh-Isleem, Nidal Jaradat & Abdel-Naser Zaid. (2016) Montelukast, current indications and prospective future applications. Expert Review of Respiratory Medicine 10:9, pages 943-956.
Read now
Read now
Yves Pacheco, Nathalie Freymond & Gilles Devouassoux. (2014) Impact of montelukast on asthma associated with rhinitis, and other triggers and co-morbidities. Journal of Asthma 51:1, pages 1-17.
Read now
Read now
Hiroto Matsuse & Shigeru Kohno. (2014) Leukotriene receptor antagonists pranlukast and montelukast for treating asthma. Expert Opinion on Pharmacotherapy 15:3, pages 353-363.
Read now
Read now
Annette J Theron, Helen C Steel, Gregory R Tintinger, Charles Feldman & Ronald Anderson. (2013) Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?. Drug Design, Development and Therapy 7, pages 1387-1398.
Read now
Read now
Neil G. Snowise, Diane Clements, Shu-Yen Ho & Richard M.A. Follows. (2013) Addition of a 5-lipoxygenase-activating protein inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting beta-2-agonist combination in subjects with asthma. Current Medical Research and Opinion 29:12, pages 1663-1674.
Read now
Read now
Salima Amlani, Thanu Nadarajah & Richard Andrew McIvor. (2011) Montelukast for the treatment of asthma in the adult population. Expert Opinion on Pharmacotherapy 12:13, pages 2119-2128.
Read now
Read now
Salima Amlani & R Andrew McIvor. (2011) Montelukast in childhood asthma: what is the evidence for its use?. Expert Review of Respiratory Medicine 5:1, pages 17-25.
Read now
Read now
Werner Schlick, Wolfgang Pohl, Karl P. Pfeiffer, Kurt Aigner, Günter Forche, Meinhard Kneussl & Hartmut Zwick. (2010) Evaluation of 3–5 months’ add-on therapy with montelukast in patients with non-controlled asthma in Austria: the STAR open-label, real-world, observational study. Current Medical Research and Opinion 26:3, pages 561-570.
Read now
Read now
Zuzana Diamant, Eva Mantzouranis & Leif Bjermer. (2009) Montelukast in the treatment of asthma and beyond. Expert Review of Clinical Immunology 5:6, pages 639-658.
Read now
Read now
Articles from other publishers (10)
NH Krishna, Amita Nene, Mahavir Modi, Tanvir Reza, Ashwin Songara & Vikrant Deshmukh. (2021) Expert opinion on montelukast and acebrophylline combination in the management of asthma. Indian Journal of Allergy, Asthma and Immunology 35:2, pages 48.
Crossref
Crossref
Nguyen Van Tho, Hye Yun Park & Yasutaka Nakano. (2016) Asthma-COPD overlap syndrome (ACOS): A diagnostic challenge. Respirology 21:3, pages 410-418.
Crossref
Crossref
Ritesh Agarwal, Sahajal Dhooria, AshutoshNath Aggarwal, VenkataN Maturu, InderpaulS Sehgal, Valliappan Muthu, KuruswamyT Prasad, LakshmikantB Yenge, Navneet Singh, Digambar Behera, SurinderK Jindal, Dheeraj Gupta, Thanagakunam Balamugesh, Ashish Bhalla, Dhruva Chaudhry, SunilK Chhabra, Ramesh Chokhani, Vishal Chopra, DevendraS Dadhwal, George D′Souza, Mandeep Garg, ShailendraN Gaur, Bharat Gopal, AlokeG Ghoshal, Randeep Guleria, KrishnaB Gupta, Indranil Haldar, Sanjay Jain, NirmalK Jain, VikramK Jain, AshokK Janmeja, Surya Kant, Surender Kashyap, GopiC Khilnani, Jai Kishan, Raj Kumar, ParvaizA Koul, Ashok Mahashur, AmitK Mandal, Samir Malhotra, Sabir Mohammed, PrasantaR Mohapatra, Dharmesh Patel, Rajendra Prasad, Pallab Ray, JaiK Samaria, PotsangbamSarat Singh, Honey Sawhney, Nusrat Shafiq, Navneet Sharma, Updesh PalS Sidhu, Rupak Singla, JagdishC Suri, Deepak Talwar & Subhash Varma. (2015) Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations. Lung India 32:7, pages 3.
Crossref
Crossref
P. J. Barnes, T. B. Casale, R. Dahl, I. D. Pavord & M. E. Wechsler. (2014) The Asthma Control Questionnaire as a clinical trial endpoint: past experience and recommendations for future use. Allergy 69:9, pages 1119-1140.
Crossref
Crossref
Muhasaparur Ganesan Rajanandh, Arcot Deenadayalu Nageswari & Kaliappan Ilango. (2014) Assessment of various second-line medications in addition to inhaled corticosteroid in asthma patients: a randomized controlled trial. Clinical and Experimental Pharmacology and Physiology 41:7, pages 509-513.
Crossref
Crossref
Muhasaparur G. Rajanandh, Arcot D. Nageswari & Kaliappan Ilango. (2014) Pulmonary Function Assessment in Mild to Moderate Persistent Asthma Patients Receiving Montelukast, Doxofylline, and Tiotropium With Budesonide: A Randomized Controlled Study. Clinical Therapeutics 36:4, pages 526-533.
Crossref
Crossref
Pierluigi Paggiaro & Elena Bacci. (2010) Montelukast in asthma: a review of its efficacy and place in therapy. Therapeutic Advances in Chronic Disease 2:1, pages 47-58.
Crossref
Crossref
P. Demoly. (2010) Apports des antileucotriènes dans le contrôle de l’asthme. Revue Française d'Allergologie 50:4, pages 368-374.
Crossref
Crossref
J. Christian Virchow, Anish Mehta, Li Ljungblad & Harald Mitfessel. (2010) Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: The MONtelukast In Chronic Asthma (MONICA) study. Respiratory Medicine 104:5, pages 644-651.
Crossref
Crossref
C.F. Ramsay, P. Sullivan, M. Gizycki, D. Wang, A.S. Swern, N.C. Barnes, T.F. Reiss & P.K. Jeffery. (2009) Montelukast and bronchial inflammation in asthma: A randomised, double-blind placebo-controlled trial. Respiratory Medicine 103:7, pages 995-1003.
Crossref
Crossref